News & Events

For the latest Zeno and Tyrell, Inc.

Charles Conrad, M.D.
Chief Medical Officer

Charles Conrad, M.D., serves as Tyrell’s chief medical officer. In this role, he has been instrumental in directing the application of Zeno ä . His medical and microbiological background has proved to be invaluable in the developmental stages of Zeno technology. He has helped design and implement both preclinical and clinical testing of the Zeno concept and device.

Dr. Conrad earned his B.S. in microbiology from Texas A&M University and went on to study medicine at the University of Texas Medical School at Houston . He is an associate professor in the Department of Neuro-Oncology, Division of Cancer Medicine at the University of Texas M. D. Anderson Cancer Center in Houston , Texas.

The recipient of numerous honors, awards and grants, he has served as the principal investigator or co-investigator on nearly 70 protocols. He has 16 patents filed or pending and has been published over 70 times.

Dr. Conrad’s professional memberships include Society for Neuro-Oncology, American Medical Association, American Academy of Neurology, Kansas City Neurology and Neurosurgery Society, Kansas City Round Table of Hematology/Oncology, North American Brain Tumor Consortium, American Association for Cancer Research and American Society of Clinical Oncology.

Out of the office, he enjoys spending time with his wife and three children as well as playing golf, reading and rebuilding project cars.

Zeno Press Kit

For all media inquiries, please contact Kilpatrick PR on +44 (0) 20 7381 6226 or info@kilpatrickpr.com